Functional characterization of a T-cell receptor BV6+ T-cell clone derived from a leprosy lesion

Immunology

Volumn 120, Issue 3, 2007, Pages 354-361

  Sabet, Shereen ^a   Ochoa, Maria Teresa ^a   Sieling, Peter A ^a   Rea, Thomas H ^b   Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bacteria; Major histocompatibility complex; T cell; T cell receptor BV genes

Indexed keywords

GRANULYSIN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ARTICLE; CELL CLONE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXOCYTOSIS; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEPROSY; MALE; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; T LYMPHOCYTE;

ANTIGENS, BACTERIAL; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; LEPROSY; MALE; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM LEPRAE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33846916048     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02510.x     Document Type: Article

References (44)

1. Leprosy. Global situation. Wkly Epidemiol Rec 2002; 77:1-8.
2. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254:279-82.
3. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277-9.
4. Modlin RL, Melancon-Kaplan J, Young SMM, Pirmez C, Kino H, Convit J, Rea TH, Bloom BR. Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci USA 1988; 85:1213-17.
5. Wang X, Golkar L, Uyemura K, et al. T cells bearing Vβ6 T-cell receptors in the cell-mediated immune response to Mycobacterium leprae. J Immunol 1993; 151:7105-16.
6. Wang X-H, Ohmen JD, Uyemura K, Rea TH, Kronenberg M, Modlin RL. Selection of T lymphocytes bearing limited T-cell receptor beta chains in the response to a human pathogen. Proc Natl Acad Sci USA 1993; 90:188-92.
7. Yamamura M, Wang X-H, Ohmen JD, Uyemura K, Rea TH, Bloom BR, Modlin RL. Cytokine patterns of immunologically mediated tissue damage. J Immunol 1992; 149:1470-5.
8. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr 1966; 34:255-73.
9. Modlin RL, Mehra V, Wong L, et al. Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol 1986; 137:2831-4.
10. Mehra V, Bloom BR, Bajardi AC, et al. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med 1992; 175:275-84.
11. Beckman EM, Melian A, Behar SM, et al. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol 1996; 157:2795-803.
12. Hirschfield GR, McNeil M, Brennan PJ. Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis. J Bacteriol 1990; 172:1005-13.
13. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation. Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A 1980; 77:1588-92.
14. Behar SM, Porcelli SA, Beckman EM, Brenner MB. A pathway of costimulation that prevents anergy in CD28- T cells. B7-independent costimulation of CD1-restricted T cells. J Exp Med 1995; 182:2007-18.
15. Melian A, Geng YJ, Sukhova GK, Libby P, Porcelli SA. CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am J Pathol 1999; 155:775-86.
16. Hanson DA, Kaspar AA, Poulain FR, Krensky AM. Biosynthesis of granulysin, a novel cytolytic molecule. Mol Immunol 1999; 36:413-22.
17. Stenger S, Hanson DA, Teitlebaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998; 282:121-5.
18. Stenger S, Mazzaccaro RJ, Uyemura K, et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997; 276:1684-7.
19. Uyemura K, Deans RJ, Band H, Ohmen J, Panchamoorthy G, Morita CT, Rea TH, Modlin RL. Evidence for clonal selection of gamma/delta T-cells in response to a human pathogen. J Exp Med 1991; 174:683-92.
20. Kaplan G, Weinstein DE, Steinman RM, Levis WR, Elvers U, Patarroyo ME, Cohn ZA. An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med 1985; 162:917-29.
21. Bloom BR, Mehra V. Immunological unresponsiveness in leprosy. Immunol Rev 1984; 80:5-28.
22. Godal T, Myklestad B, Samuel DR, Myrvang B. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. Clin Exp Immunol 1971; 9:821-31.
23. Sieling PA, Chatterjee D, Porcelli SA, et al. CD1-restricted T cell recognition of microbial lipoglycans. Science 1995; 269:227-30.
24. Arden B, Clark SP, Kabelitz D, Mak TW. Human T-cell receptor variable gene segment families. Immunogenetics 1995; 42:455-500.
25. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001; 193:271-80.
26. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992; 89:12013-17.
27. Ladel CH, Hess J, Daugelat S, Mombaerts P, Tonegawa S, Kaufmann SH. Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette-Guérin: studies with T cell receptor-deficient mutant mice. Eur J Immunol 1995; 25:838-46.
28. Modlin RL, Pirmez C, Hofman FM, Torigian V, Uyemura K, Rea TH, Bloom BR, Brenner MB. Lymphocytes bearing antigen-specific gamma/delta T-cell receptors in human infectious disease lesions. Nature 1989; 339:544-8.
29. Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen H. The HLA dictionary 1999. a summary of HLA-A-B-C-DRB1/3/4/5-DQB1 alleles and their association with serologically defined HLA-A-B-C-DR, and -DQ antigens. Human Immunol 1999; 60:1157-81.
30. Tiercy JM, Jeannet M, Mach B. Oligonucleotide typing analysis for the linkage disequilibrium between the polymorphic DRB1 and DRB5 loci in DR2 haplotypes. Tissue Antigens 1991; 37:161-4.
31. Verhagen CE, Wierenga EA, Buffing AA, Chand MA, Faber WR, Das PK. Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study. J Immunol 1997; 159:4474-83.
32. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 2001; 167:2734-42.
33. Emoto M, Emoto Y, Kaufmann SH. TCR-mediated target cell lysis by CD4+NK1+ liver T lymphocytes. Int Immunol 1997; 9:563-71.
34. Lewinsohn DM, Bement TT, Xu J, Lynch DH, Grabstein KH, Reed SG, Alderson MR. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J Immunol 1998; 160:2374-9.
35. Williams NS, Engelhard VH. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells. J Immunol 1997; 159:2091-9.
36. Hedrick SM, Engel I, McElligott DL, Fink PJ, Hsu ML, Hansburg D, Matis LA. Selection of amino acid sequences in the beta chains of the T-cell antigen receptor. Science 1988; 239:1541-4.
37. Jorgensen JL, Esser U, Fazekas de St Groth B., Reay PA, Davis MM. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 1992; 355:224-30.
38. Lawson TM, Man S, Williams S, Boon AC, Zambon M, Borysiewicz LK. Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. Int Immunol 2001; 13:1373-81.
39. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, Friedman SM, Bell JI, Borysiewicz LK. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 1995; 181:79-91.
40. Moss PA, Moots RJ, Rosenberg WM, Rowland-Jones SJ, Bodmer HC, McMichael AJ, Bell JI. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA 1991; 88:8987-90.
41. Sieling PA, Wang X-H, Gately MK, et al. IL-12 regulates T helper Type 1 cytokine responses in human infectious disease. J Immunol 1994; 153:3639-47.
42. Krensky AM. Granulysin. a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Biochem Pharmacol 2000; 59:317-20.
43. Thoma-Uszynski S, Stenger S, Modlin RL. CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis. J Immunol 2000; 165:5773-9.
44. Ochoa MT, Stenger S, Sieling PA, et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001; 7:174-9.